Skip to main content
. 2024 Aug 20;15:1403420. doi: 10.3389/fimmu.2024.1403420

Figure 2.

Figure 2

Heatmap to summary the included literatures about the predictive value of lymphocyte subsets in the prediction of disease progression and response to anti-TNFα agents and vedolizumab. * represents the lymphocyte subgroups from the peripheral blood; # represents the lymphocyte subpopulations from the mucosal biopsy. One symbol (* or #) means there is one corresponding study.